Corbus Pharmaceuticals Holdings, Inc. · NASDAQ:CRBP
Orbimed Advisors LLC reported a 5.90% stake in Corbus Pharmaceuticals Holdings, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Orbimed Advisors LLC reported a 5.90% stake in Corbus Pharmaceuticals Holdings, Inc., 718,200 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 5.90%
- Shares
- 718,200
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 3.70% | 454,087 |
| OrbiMed Capital LLC | 5.90% | 718,200 |
Source
Related
- Corbus Pharmaceuticals Holdings, Inc.
- Orbimed Advisors LLC
- Corbus Pharmaceuticals Holdings, Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Sep 30, 2026
- Form 4 · Ben Yong · Sep 15, 2026
- Form 4 · Nicacio Leonardo Viana · Aug 17, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Form 4 · Saxena Nishant C · Aug 12, 2026